Literature DB >> 20173750

Marker-independent identification of glioma-initiating cells.

Virginie Clément1, Denis Marino, Cristina Cudalbu, Marie-France Hamou, Vladimir Mlynarik, Nicolas de Tribolet, Pierre-Yves Dietrich, Rolf Gruetter, Monika E Hegi, Ivan Radovanovic.   

Abstract

Tumor-initiating cells with stem cell properties are believed to sustain the growth of gliomas, but proposed markers such as CD133 cannot be used to identify these cells with sufficient specificity. We report an alternative isolation method purely based on phenotypic qualities of glioma-initiating cells (GICs), avoiding the use of molecular markers. We exploited intrinsic autofluorescence properties and a distinctive morphology to isolate a subpopulation of cells (FL1(+)) from human glioma or glioma cultures. FL1(+) cells are capable of self-renewal in vitro, tumorigenesis in vivo and preferentially express stem cell genes. The FL1(+) phenotype did not correlate with the expression of proposed GIC markers. Our data propose an alternative approach to investigate tumor-initiating potential in gliomas and to advance the development of new therapies and diagnostics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173750     DOI: 10.1038/nmeth.1430

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  29 in total

1.  Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.

Authors:  F Doetsch; I Caillé; D A Lim; J M García-Verdugo; A Alvarez-Buylla
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

2.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

Authors:  S G M Piccirillo; B A Reynolds; N Zanetti; G Lamorte; E Binda; G Broggi; H Brem; A Olivi; F Dimeco; A L Vescovi
Journal:  Nature       Date:  2006-12-07       Impact factor: 49.962

3.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

4.  N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation.

Authors:  Deric M Park; Jie Li; Hiroaki Okamoto; Oluwaseun Akeju; Stephanie H Kim; Irina Lubensky; Alexander Vortmeyer; James Dambrosia; Robert J Weil; Edward H Oldfield; John K Park; Zhengping Zhuang
Journal:  Cell Cycle       Date:  2007-02-12       Impact factor: 4.534

5.  CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.

Authors:  Jian Wang; Per Ø Sakariassen; Oleg Tsinkalovsky; Heike Immervoll; Stig Ove Bøe; Agnete Svendsen; Lars Prestegarden; Gro Røsland; Frits Thorsen; Linda Stuhr; Anders Molven; Rolf Bjerkvig; Per Ø Enger
Journal:  Int J Cancer       Date:  2008-02-15       Impact factor: 7.396

6.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Authors:  Heidi S Phillips; Samir Kharbanda; Ruihuan Chen; William F Forrest; Robert H Soriano; Thomas D Wu; Anjan Misra; Janice M Nigro; Howard Colman; Liliana Soroceanu; P Mickey Williams; Zora Modrusan; Burt G Feuerstein; Ken Aldape
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  Limits of CD133 as a marker of glioma self-renewing cells.

Authors:  Virginie Clément; Valérie Dutoit; Denis Marino; Pierre-Yves Dietrich; Ivan Radovanovic
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

8.  The fuzzy math of solid tumor stem cells: a perspective.

Authors:  Scott E Kern; Darryl Shibata
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

9.  Cancerous stem cells can arise from pediatric brain tumors.

Authors:  Houman D Hemmati; Ichiro Nakano; Jorge A Lazareff; Michael Masterman-Smith; Daniel H Geschwind; Marianne Bronner-Fraser; Harley I Kornblum
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205

Review 10.  The hunt for cancer-initiating cells: a history stemming from leukemia.

Authors:  M P Buzzeo; E W Scott; C R Cogle
Journal:  Leukemia       Date:  2007-05-31       Impact factor: 11.528

View more
  29 in total

1.  Quantum-like interference effect in gene expression: glucose-lactose destructive interference.

Authors:  Irina Basieva; Andrei Khrennikov; Masanori Ohya; Ichiro Yamato
Journal:  Syst Synth Biol       Date:  2011-03-20

Review 2.  Reactive oxygen species in cancer stem cells.

Authors:  Xiaoke Shi; Yan Zhang; Junheng Zheng; Jingxuan Pan
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

3.  Retraction: Marker-independent identification of glioma-initiating cells.

Authors: 
Journal:  Nat Methods       Date:  2013-10       Impact factor: 28.547

Review 4.  Glioblastoma cancer stem cells: Biomarker and therapeutic advances.

Authors:  Kelli B Pointer; Paul A Clark; Michael Zorniak; Bahauddeen M Alrfaei; John S Kuo
Journal:  Neurochem Int       Date:  2014-03-19       Impact factor: 3.921

5.  The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence.

Authors:  Ichiyo Shibahara; Yukihiko Sonoda; Ryuta Saito; Masayuki Kanamori; Yoji Yamashita; Toshihiro Kumabe; Mika Watanabe; Hiroyoshi Suzuki; Takashi Watanabe; Chikashi Ishioka; Teiji Tominaga
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300

6.  Cell-line authentication demystified.

Authors:  Vivien Marx
Journal:  Nat Methods       Date:  2014-04-29       Impact factor: 28.547

Review 7.  Strategies for isolating and enriching cancer stem cells: well begun is half done.

Authors:  Jiang-Jie Duan; Wen Qiu; Sen-Lin Xu; Bin Wang; Xian-Zong Ye; Yi-Fang Ping; Xia Zhang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Stem Cells Dev       Date:  2013-05-09       Impact factor: 3.272

8.  Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma.

Authors:  Simon K Hermansen; Karina G Christensen; Stine S Jensen; Bjarne W Kristensen
Journal:  J Histochem Cytochem       Date:  2011-04       Impact factor: 2.479

Review 9.  Glioma stem cell maintenance: the role of the microenvironment.

Authors:  John M Heddleston; Masahiro Hitomi; Monica Venere; William A Flavahan; Kenneth Yang; Youngmi Kim; Sana Minhas; Jeremy N Rich; Anita B Hjelmeland
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 10.  Technologies for deriving primary tumor cells for use in personalized cancer therapy.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Trends Biotechnol       Date:  2013-04-16       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.